About Vibalogics
Vibalogics is a company based in Cuxhaven (Germany) founded in 2007 was acquired by Recipharm in February 2022. Vibalogics offers products and services including RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing. Vibalogics operates in a competitive market with competitors including Wacker Chemie, AMILI, Enduro, BioCina and Eleszto Genetika, among others.
- Headquarter Cuxhaven, Germany
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Recipharm Ab
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vibalogics
Vibalogics offers a comprehensive portfolio of products and services, including RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing.
Service for producing RNA therapies and related components
Process for manufacturing plasmid DNA for therapeutic use
Development and production of viral vectors for medical applications
Funding Insights of Vibalogics
Investors in Vibalogics
Vibalogics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Recipharm, Innovative Health Initiative and Ampersand Capital Partners.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Ampersand Capital Partners is focused on investments in healthcare and life sciences.
|
Locked | Locked | Locked | |
|
Health research and innovation are funded through public-private partnerships.
|
Locked | Locked | Locked | |
|
Pharmaceutical development and manufacturing services are offered contractually.
|
Locked | Locked | Locked |
Investor details for Vibalogics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Vibalogics
Investment portfolio details for Vibalogics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Vibalogics
Detailed financials for Vibalogics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Vibalogics Comparisons
Peer comparison for Vibalogics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Vibalogics
Vibalogics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Wacker Chemie, AMILI, Enduro, BioCina and Eleszto Genetika, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Silicones, polymers, and bio-solutions are manufactured for various industries.
|
|
| Locked | Locked | Locked |
Gut microbiome insights, analytics, tests, and therapeutics are provided.
|
|
| Locked | Locked | Locked |
Microbial strains are manufactured by Enduro as a CDMO.
|
|
| Locked | Locked | Locked |
CDMO offering microbial expression systems-based biologics development and manufacturing services
|
|
| Locked | Locked | Locked |
CDMO offers microbial expression systems-based biologics development
|
|
| Locked | Locked | Locked |
Offers microbial expression systems-based biologics development and manufacturing services
|
Detailed competitors of Vibalogics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Vibalogics
Complete news archive for Vibalogics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Vibalogics
Vibalogics was founded in 2007 and raised its 1st funding round 8 years after it was founded.
Vibalogics is headquartered in Cuxhaven, Germany. It is registered at Cuxhaven, Lower Saxony, Germany.
Vibalogics is a CDMO offering development, cGMP manufacturing and fillfinish of products based on viruses and bacteria for companies involved in the development of vaccines, gene and oncolytic viral therapies in the biopharmaceutical industry. Vibalogics is capable of all carrying out all activities for clinical drug development right from feasibility assessment to product release for companies committed to developing therapeutic prophylactic vaccines and biological products, based on viruses, live bacteria and aseptic processing. Their manufacturing facility is GMP compliant, BSL-2 classified and has been inspected and approved by European regulatory agencies. Vibalogics is part of the consortium lead by JJ and funded by IMI (Innovative Medicines Initiative) for Ebola Vaccine development.
Vibalogics's top competitors include Wacker Chemie, AMILI and Enduro.
Vibalogics offers RNA Manufacturing, Plasmid Manufacturing, and Viral Vector Manufacturing.
Vibalogics has 3 investors. Key investors include Recipharm, Innovative Health Initiative, and Ampersand Capital Partners.